MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517021372 A) filed by Shanghai Forefront Pharma Co. Ltd., Shanghai, on March 10, for 'new prostacyclin for treating pulmonary hypertension.'
Inventor(s) include Ren Yi; Zhu Lingui; and Huang Jincheng.
The application for the patent was published on June 6, under issue no. 23/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a new prostacyclin for treating pulmonary hypertension. Specifically the compound of the present invention has the structure as represented by formula (I) wherein the definition of each group and substituent is as described in the description. Compared with treprostin...